AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over UCL overall, supported by stronger fundamentals.
UCL
uCloudlink Group Inc.
UCL has slightly lower modeled downside risk, despite its lower overall score.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
UCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Strong |
UCL's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
UCL PE Valuation
UCL has no meaningful PE right now: it lost money over the past year.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect UCL to return to profit, with revenue growing.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
UCL has the stronger earnings trend. Trailing diluted EPS is down 130% for AMC versus UCL down 20%.
UCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | $0.12 | +$0.27 |
| Q1 2024 | $0.03 | +$0.36 |
| Q4 2023 | $0.08 | +$0.74 |
| Q3 2023 | $0.10 | +$1.27 |
| Q2 2023 | -$0.15 | +$1.12 |
| Q1 2023 | -$0.33 | +$1.02 |
| Q4 2022 | -$0.66 | +$0.96 |
| Q3 2022 | -$1.17 | +$0.35 |
UCL has returned to profit: it earned $0.12 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over UCL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over UCL on profitability, with a higher operating margin.
UCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.2M | -5.9% |
| Q1 2026 | $16.9M | -10% |
| Q4 2025 | $22.3M | -14% |
| Q3 2025 | $21.2M | -16% |
| Q2 2025 | $19.4M | -13% |
| Q1 2025 | $18.7M | +3.4% |
| Q4 2024 | $26M | +19% |
| Q3 2024 | $25.2M | +5.6% |
UCL's revenue has slid since its 2019 peak: $18M last quarter, down 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -16% | -20 points |
| Q1 2026 | -16% | -13 points |
| Q4 2025 | 8.5% | +15 points |
| Q3 2025 | 0.6% | -13 points |
| Q2 2025 | 4.2% | -5.9 points |
| Q1 2025 | -2.5% | -5.3 points |
| Q4 2024 | -6.6% | +1.9 points |
| Q3 2024 | 13% | -0.7 points |
UCL's operating margin was −16% last quarter, down 20 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over UCL on cash generation, producing positive trailing cash flow while its opponent burns cash.
UCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.1M | -$2M |
| Q1 2026 | -$8.7M | -$8.7M |
| Q4 2025 | $4.4M | +$7.8M |
| Q3 2025 | -$1.4M | -170% |
| Q2 2025 | -$1.1M | -135% |
| Q1 2025 | -$64K | -105% |
| Q4 2024 | -$3.5M | -$80K |
| Q3 2024 | $2M | +1.2% |
UCL has burned cash in six of the last eight quarters: −$9M over the past year, against −$3M the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
UCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +163K shares |
| 1 year | +1.3% | +478K shares |
| 3 years | +33% | +9.3M shares |
| 5 years | +44% | +11.6M shares |
UCL has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
UCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -4.0x | Net Cash |
| Q2 2024 | -3.4x | Net Cash |
| Q1 2024 | -7.9x | Net Cash |
| Q4 2023 | -4.4x | Net Cash |
UCL has the edge over AMC on leverage, with a lower net debt burden relative to earnings.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
UCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.1 | Oversold |
| Stochastic | 4.7 | Oversold |
UCL's weekly RSI is 19 (oversold) and its Stochastic is 5 (oversold).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
UCL PE vs Communication Services Sector
| Metric | UCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
UCL has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over UCL on trend strength, trading above more of its moving averages.
UCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 12% below |
| 20 week MA | $0.50 | 56% below |
| 50 week MA | $1.07 | 79% below |
| 100 week MA | $1.49 | 85% below |
| 200 week MA | $1.90 | 88% below |
UCL is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over UCL on returns for 2026, with the stronger performance.
UCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $10.4 | -37% |
| 2021 | $10.4 | $3.30 | -68% |
| 2022 | $3.30 | $3.97 | +20% |
| 2023 | $3.97 | $1.75 | -56% |
| 2024 | $1.75 | $2.40 | +37% |
| 2025 | $2.40 | $2.05 | -15% |
| 2026 YTD | $2.05 | $0.22 | -89% |
UCL has finished lower in four of the last six years. It's down 89% so far in 2026.